Caleb Appleton is a Partner at Bison Ventures, where he focuses on investing in transformational technology companies that are reshaping global markets. He also holds a position as a Seed Investor at Eikon Therapeutics, a role he has held since May 2021.
Appleton contributes to the academic and scientific community as a Board Member at The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, a role he has maintained since 2019.